Device manufacturer, as written on reports
Bard Access Systems: medical device reports filed with FDA
21,057 reports name it as the manufacturer of the device involved, 1992–2026.
- 21,057
- reports naming it as manufacturer
- 0.1% of all MAUDE reports
- 118
- reports, 12 months to August 2026
- 207 in the 12 months before
- 78.3%
- classified as malfunction
- 62.3% across all reports
- 0.8%
- classified as death, as reported
- 0.9% across all reports
21,057 medical device reports received by FDA give Bard Access Systems as the manufacturer of the device involved, 0.1% of the MAUDE database, from July 1992 to August 2026. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.
118 reports arrived in the 12 months to August 2026, down 43% from 207 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (78.3%), injury (19.8%) and death (0.8%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands named most often
| Brand | Device type | Reports | Latest 12 months | Classified as death |
|---|---|---|---|---|
| Groshong Nxt Clearvue 4f Single-Lumen Basic Tray With Safety Introducer | Catheter, intravascular, therapeutic, long-term greater than 30 days | 387 | 0 | 0.1% |
| Groshong Nxt Clearvue 4f Single-Lumen Picc Basic Tray With Microintroducer | Catheter, intravascular, therapeutic, long-term greater than 30 days | 312 | 0 | 0.5% |
| Powerpicc Solo Catheter With Sherlock 3cg Tip Positioning System Tps Stylet 4f | Catheter, intravascular, therapeutic, long-term greater than 30 days | 252 | 0 | 0% |
| Site-Rite 8 Ultrasound | System, imaging, pulsed echo, ultrasonic | 247 | 0 | 0% |
| Bard | Port & catheter, implanted, subcutaneous, intravascular | 188 | 2 | 1.8% |
| Universal Microintroducer Kit Ptfe Peel-Apart Sheath Introducer 4 5f X 5cm | Introducer, catheter | 176 | 0 | 0% |
| Per-Q-Cath Plus 2f Single-Lumen Picc With Stiffening Stylet Basic Tray 30 Cm | Catheter, intravascular, therapeutic, long-term greater than 30 days | 169 | 0 | 0% |
| Safestep Huber Needle Set 20g X 0 75in With Y-Site | Set, administration, intravascular | 139 | 0 | 0% |
| Safestep Huber Needle Set 20g X 0 75in | Set, administration, intravascular | 116 | 0 | 0% |
| PowerPICC Provena | Catheter, intravascular, therapeutic, long-term greater than 30 days | 107 | 102 | 0% |
| Safestep Huber Needle Set 22g X 0 75in | Set, administration, intravascular | 87 | 0 | 0% |
| Bard PICC | Catheter, intravascular, therapeutic, long-term greater than 30 days | 79 | 84 | 0% |
| Powerloc Max Power-Injectible Infusion Set 20g X 0 75in | Set, administration, intravascular | 76 | 0 | 0% |
| Port Access Needle | Set, administration, intravascular | 73 | 16 | 0% |
| Site Rite 8 Ultrasound System Console With Connector | System, imaging, pulsed echo, ultrasonic | 73 | 0 | 0% |
| Unknown Port | Port & catheter, implanted, subcutaneous, intravascular | 73 | 16 | 0.7% |
| Site-Rite 8 Ultrasound Systsem Console Remanufactured | System, imaging, pulsed echo, ultrasonic | 67 | 0 | 0% |
| Groshong Catheter | Catheter, intravascular, diagnostic | 62 | 58 | 1.9% |
| Groshong 4f Single-Lumen Picc 60cm | Catheter, intravascular, therapeutic, long-term greater than 30 days | 53 | 0 | 0% |
| PowerPICC | Catheter, intravascular, therapeutic, long-term greater than 30 days | 50 | 577 | 0.1% |
| Statlock Picc Plus Crescent Sliding Post | Stand, infusion | 29 | 0 | 0% |
| PowerPort isp M.R.I. Implantable Port, Groshong Single-Lumen, 8F | Port & catheter, implanted, subcutaneous, intravascular | 28 | 211 | 1.3% |
| Powerloc Safety Infusion Set 20g X 0 75in | Set, administration, intravascular | 22 | 0 | 0% |
| HemoSplit Catheter | Catheter, hemodialysis, implanted | 15 | 49 | 1.6% |
| Catheter | Pump, infusion, implanted, programmable | 14 | 9 | 3.7% |
| Implanted Port | Port & catheter, implanted, subcutaneous, intravascular | 10 | 368 | 4.3% |
| PowerLoc | Set, administration, intravascular | 10 | 231 | 0% |
| Port-A-Cath | Port & catheter, implanted, subcutaneous, intravascular | 6 | 0 | 0% |
| Groshong Nxt Clearvue 4f Single-Lumen Picc Basic Tray | Catheter, intravascular, therapeutic, long-term greater than 30 days | 3 | 0 | 0.3% |
| PowerPort Slim Implantable Port, ChronoFlex Single-Lumen, 6F | Port & catheter, implanted, subcutaneous, intravascular | 2 | 77 | 4.7% |
Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Device types
| Product code | Device type | Reports | Share |
|---|---|---|---|
| LJS | Catheter, intravascular, therapeutic, long-term greater than 30 days | 8,322 | 39.5% |
| LJT | Port & catheter, implanted, subcutaneous, intravascular | 3,120 | 14.8% |
| DQO | Catheter, intravascular, diagnostic | 1,776 | 8.4% |
| FPA | Set, administration, intravascular | 1,764 | 8.4% |
| MSD | Catheter, hemodialysis, implanted | 1,169 | 5.6% |
| FOZ | Catheter, intravascular, therapeutic, short-term less than 30 days | 1,060 | 5% |
| IYO | System, imaging, pulsed echo, ultrasonic | 748 | 3.6% |
| KNT | Tubes, gastrointestinal (and accessories) | 503 | 2.4% |
| LFJ | Catheter, subclavian | 344 | 1.6% |
| DYB | Introducer, catheter | 303 | 1.4% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type
Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.
Questions about Bard Access Systems reports
How many FDA device reports name Bard Access Systems as manufacturer?
21,057 reports through August 2026, 118 of them in the latest 12 months.
Which of its brands appear most often?
Groshong Nxt Clearvue 4f Single-Lumen Basic Tray With Safety Introducer (387), Groshong Nxt Clearvue 4f Single-Lumen Picc Basic Tray With Microintroducer (312), Powerpicc Solo Catheter With Sherlock 3cg Tip Positioning System Tps Stylet 4f (252), Site-Rite 8 Ultrasound (247) and Bard (188).
Which device types does it report on?
catheter, intravascular, therapeutic, long-term greater than 30 days (39.5%), port & catheter, implanted, subcutaneous, intravascular (14.8%), catheter, intravascular, diagnostic (8.4%) and set, administration, intravascular (8.4%).
Does a high count say something about the manufacturer?
Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.